BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18793158)

  • 1. Glucolipotoxicity of the pancreatic beta-cell: myth or reality?
    Poitout V
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):901-4. PubMed ID: 18793158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass.
    Fontés G; Zarrouki B; Hagman DK; Latour MG; Semache M; Roskens V; Moore PC; Prentki M; Rhodes CJ; Jetton TL; Poitout V
    Diabetologia; 2010 Nov; 53(11):2369-79. PubMed ID: 20628728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucolipotoxicity of the pancreatic beta cell.
    Poitout V; Amyot J; Semache M; Zarrouki B; Hagman D; Fontés G
    Biochim Biophys Acta; 2010 Mar; 1801(3):289-98. PubMed ID: 19715772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes.
    Lytrivi M; Castell AL; Poitout V; Cnop M
    J Mol Biol; 2020 Mar; 432(5):1514-1534. PubMed ID: 31628942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activity.
    Somesh BP; Verma MK; Sadasivuni MK; Mammen-Oommen A; Biswas S; Shilpa PC; Reddy AK; Yateesh AN; Pallavi PM; Nethra S; Smitha R; Neelima K; Narayanan U; Jagannath MR
    BMC Cell Biol; 2013 Jul; 14():31. PubMed ID: 23815372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cholinergic potentiation of insulin secretion from pancreatic islets by chronic elevation of glucose and fatty acids: Protection by casein kinase 2 inhibitor.
    Doliba NM; Liu Q; Li C; Chen P; Liu C; Naji A; Matschinsky FM
    Mol Metab; 2017 Oct; 6(10):1240-1253. PubMed ID: 29031723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pancreatic beta-cell in human Type 2 diabetes.
    Marchetti P; Del Prato S; Lupi R; Del Guerra S
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S3-6. PubMed ID: 16530127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of dying beta cell originated messenger molecules in differentiation of pancreatic mesenchymal stem cells under glucotoxic and glucolipotoxic conditions.
    Gezginci-Oktayoglu S; Onay-Ucar E; Sancar-Bas S; Karatug-Kacar A; Arda ESN; Bolkent S
    J Cell Physiol; 2018 May; 233(5):4235-4244. PubMed ID: 29058819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucolipotoxicity: fuel excess and beta-cell dysfunction.
    Poitout V; Robertson RP
    Endocr Rev; 2008 May; 29(3):351-66. PubMed ID: 18048763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.
    Delghingaro-Augusto V; Décary S; Peyot ML; Latour MG; Lamontagne J; Paradis-Isler N; Lacharité-Lemieux M; Akakpo H; Birot O; Nolan CJ; Prentki M; Bergeron R
    Am J Physiol Endocrinol Metab; 2012 Jan; 302(2):E254-64. PubMed ID: 22045312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of the ELOVL2/docosahexaenoic acid axis in glucolipotoxicity-induced apoptosis in rodent beta cells and human islets.
    Bellini L; Campana M; Rouch C; Chacinska M; Bugliani M; Meneyrol K; Hainault I; Lenoir V; Denom J; Véret J; Kassis N; Thorens B; Ibberson M; Marchetti P; Blachnio-Zabielska A; Cruciani-Guglielmacci C; Prip-Buus C; Magnan C; Le Stunff H
    Diabetologia; 2018 Aug; 61(8):1780-1793. PubMed ID: 29754287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of peroxisome proliferator-activated receptor gamma-coactivator-1alpha normalizes the glucolipotoxicity-induced decreased BETA2/NeuroD gene transcription and improved glucose tolerance in diabetic rats.
    Kim JW; You YH; Ham DS; Cho JH; Ko SH; Song KH; Son HY; Suh-Kim H; Lee IK; Yoon KH
    Endocrinology; 2009 Sep; 150(9):4074-83. PubMed ID: 19520786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucolipotoxicity Alters Insulin Secretion via Epigenetic Changes in Human Islets.
    Hall E; Jönsson J; Ofori JK; Volkov P; Perfilyev A; Dekker Nitert M; Eliasson L; Ling C; Bacos K
    Diabetes; 2019 Oct; 68(10):1965-1974. PubMed ID: 31420409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal nitric oxide synthase protects the pancreatic beta cell from glucolipotoxicity-induced endoplasmic reticulum stress and apoptosis.
    Bachar E; Ariav Y; Cerasi E; Kaiser N; Leibowitz G
    Diabetologia; 2010 Oct; 53(10):2177-87. PubMed ID: 20596694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Combination of Whole Cell Lipidomics Analysis and Single Cell Confocal Imaging of Fluidity and Micropolarity Provides Insight into Stress-Induced Lipid Turnover in Subcellular Organelles of Pancreatic Beta Cells.
    Maulucci G; Cohen O; Daniel B; Ferreri C; Sasson S
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31627330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclical and alternating infusions of glucose and intralipid in rats inhibit insulin gene expression and Pdx-1 binding in islets.
    Hagman DK; Latour MG; Chakrabarti SK; Fontes G; Amyot J; Tremblay C; Semache M; Lausier JA; Roskens V; Mirmira RG; Jetton TL; Poitout V
    Diabetes; 2008 Feb; 57(2):424-31. PubMed ID: 17991758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADPH oxidase mediates glucolipotoxicity-induced beta cell dysfunction--clinical implications.
    McCarty MF; Barroso-Aranda J; Contreras F
    Med Hypotheses; 2010 Mar; 74(3):596-600. PubMed ID: 19576699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Paradoxical Effects of AMPK on Insulin Gene Expression and Glucose-Induced Insulin Secretion.
    Kim JW; You YH; Ham DS; Yang HK; Yoon KH
    J Cell Biochem; 2016 Jan; 117(1):239-46. PubMed ID: 26105159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose amplifies fatty acid-induced endoplasmic reticulum stress in pancreatic beta-cells via activation of mTORC1.
    Bachar E; Ariav Y; Ketzinel-Gilad M; Cerasi E; Kaiser N; Leibowitz G
    PLoS One; 2009; 4(3):e4954. PubMed ID: 19305497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond.
    Moon JS; Karunakaran U; Suma E; Chung SM; Won KC
    Diabetes Metab J; 2020 Apr; 44(2):222-233. PubMed ID: 32347024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.